Browsing Tag
Wockhardt Limited
3 posts
Wockhardt delivers strong FY25 EBITDA, but net loss persists amid US restructuring drag
Wockhardt posts a 67% EBITDA jump in FY25, but Q4 PAT remains negative. Find out how novel antibiotics like Zaynich and Miqnaf are shaping investor sentiment.
Wockhardt sees Q2 revenue surge, driven by antibiotic innovation and biosimilar expansion
Wockhardt Limited, a leading pharmaceutical and biotechnology company, released its second-quarter financial results for the fiscal year 2024-25,…
Wockhardt UK and Serum Life Sciences UK join forces to deliver 150 million vaccine doses annually from new fill-finish facility
Find out how Wockhardt and Serum Life Sciences UK are reshaping global vaccine supply with a new high-capacity facility—read more now.